Concepedia

Daniel Bridges

DB

8

Publications

1.3K

Citations

8

H-Index

1998

Active since

Affiliations

Chelsea and Westminster Hospital(Current)

Pfizer (United States)

Daniel Bridges is an author at Chelsea and Westminster Hospital specializing in medicine, neuroscience, and research ethics.

Top concepts

MedicineNeuroscienceHealth PolicyResearch EthicsSocial SciencesNeuropharmacologyClinical GuidelinesNeurologyCannabinoidsNeuroanatomy

Publications per year

1998–2022

8

Publications

8

Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3

Wendy P. Battisti, Elizabeth Wager, Lise Baltzer et al. · Annals of Internal Medicine · 2015 · 341 citations · Full text

Patient-oriented Research, Steering Committee, Medical Ethics +13

Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update

Lisa DeTora, Dikran Toroser, Angela Sykes et al. · Annals of Internal Medicine · 2022 · 243 citations

Preclinical Therapeutics, Biomedical Ethic, Clinical Guidelines +17

The synthetic cannabinoid WIN55,212‐2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain

Daniel Bridges, Kamran Ahmad, Andrew S.C. Rice · British Journal of Pharmacology · 2001 · 219 citations · Full text

Localisation of cannabinoid receptor 1 in rat dorsal root ganglion using in situ hybridisation and immunohistochemistry

Daniel Bridges, Andrew S.C. Rice, Michaela Egertová et al. · Neuroscience · 2003 · 165 citations

Cannabinoid Receptor 1, Cannabis Use, Functional Selectivity +10

Good publication practice for communicating company sponsored medical research: the GPP2 guidelines

Chris Graf, Wendy P. Battisti, Daniel Bridges et al. · BMJ · 2009 · 124 citations · Full text

Gpp2 Guidelines, Evidence-based Medicine, Clinical Specialties +17

Rows per page

1–5 of 8